Category Ranking

98%

Total Visits

921

Avg Visit Duration

2 minutes

Citations

20

Article Abstract

Objective: Racial and ethnic disparities exist in opioid-related overdose death rates and engagement with substance use disorder (SUD) treatment. Emerging peer recovery support services (PRSS) show promise in engaging and supporting marginalized populations. Recovery community centers (RCCs) are an important and growing source of community-based PRSS. Our goal was to examine if RCCs serving Black, Hispanic/Latino, or other racial/ethnic communities successfully engage marginalized populations in their community and if there are differences in the service models and functioning of RCCs serving different racial/ethnic communities.

Methods: We conducted exploratory secondary analyses of a nationwide survey of RCC directors ( = 122), in which directors described their RCC in terms of logistics, footprints, service model, linkages, services, and attitudes toward medication treatment. Analysis of variance and chi-square tests were used to compare RCCs serving different communities (i.e., Black, Hispanic/Latino, Other) on these variables, where "serving a Black/Hispanic/Latino community" was operationally defined as being in a ZIP code with more than double the national prevalence of Black (13.6%) and Hispanic/Latino (19.1%) individuals in the United States.

Results: On average, the median [IQR] percentage of Black participants within RCCs serving Black communities was 45% [30-63%] (51% of residents in the RCCs' ZIP codes were Black); in RCCs serving Hispanic/Latino communities, 50% [28-60%] of RCC participants were Hispanic/Latino (57% of residents in the RCCs' ZIP codes were Hispanic/Latino). Across 70 variables describing the RCCs' service model and functioning, only two statistically significant differences emerged between RCCs serving Black, Hispanic/Latino, and other communities, using an alpha of 0.05. RCCs differed in offering 12-step mutual aid groups (lowest in RCCs serving Hispanic/Latino communities; = 0.03) and the existence of direct collaboration with clinical sites providing medications for opioid use disorder (MOUD, most common in RCCs serving Black communities; = 0.03).

Conclusion: The overall RCC model appears to be consistent across racial/ethnic settings in terms of footprints, model of care, services offered, connection to relevant systems and organizations, and attitudes toward medications. Given the commonly observed racial/ethnic disparities in SUD care, the robustness of the RCC model across communities is promising.

Download full-text PDF

Source
http://www.ncbi.nlm.nih.gov/pmc/articles/PMC12263450PMC
http://dx.doi.org/10.3389/fpubh.2025.1532488DOI Listing

Publication Analysis

Top Keywords

rccs serving
36
serving black
20
black hispanic/latino
16
hispanic/latino communities
16
rccs
11
serving
9
black
9
hispanic/latino
9
communities
9
recovery community
8

Similar Publications

Background: Immune checkpoint inhibitors (ICIs) are a cornerstone of systemic therapy for clear cell renal cell carcinoma (ccRCC), yet response rates remain variable and predictive biomarkers are lacking. This study aimed to determine whether baseline levels of myeloid-derived suppressor cells (MDSCs), especially monocytic (M-MDSC) and polymorphonuclear (PMN-MDSC) subtypes, could predict ICI response in ccRCC patients.

Methods: In this prospective cohort study, 20 ccRCC patients receiving ICI-based therapy for at least 3 months were enrolled.

View Article and Find Full Text PDF

Dual primary malignancy is a rare but possible malignancy presentation. Here, we present two cases of synchronous renal cell cancer and colon cancer with simultaneous laparoscopic management. The first patient, a 65-year-old female, reported painless hematochezia, while the second, a 73-year-old female, complained of painful bloating and constipation, along with a palpable mass in the left lower quadrant of the abdomen.

View Article and Find Full Text PDF

Background: Select patients with metastatic clear-cell renal-cell carcinoma can be treated without systemic therapy, yet few studies have explored this population. We investigated the efficacy of metastasis-directed therapy without systemic therapy in oligometastatic clear-cell renal-cell carincoma.

Methods: This investigator-initiated single-arm, phase 2 trial enrolled patients aged 18 years or older with an Eastern Cooperative Oncology Group performance status of 0-2, histologically confirmed clear-cell renal-cell carcinoma, and one to five metastases.

View Article and Find Full Text PDF

Background: Inflammation impacts the prognosis of numerous types of tumors. Inflammatory indicators such as the neutrophil-to-lymphocyte ratio, lymphocyte-to-monocyte ratio, and neutrophil-to-eosinophil ratio (NER) have emerged as potential prognostic markers and are closely correlated with the outcomes of cancer patients. However, the connection between NER and cancer prognosis remains incompletely understood.

View Article and Find Full Text PDF

Background/aim: Clear cell renal cell carcinoma (ccRCC) is among the 10 most common cancers diagnosed in the United States. Despite its severity and aggressive nature, biomarkers that can serve as prognostic and predictive factors for ccRCC are lacking. ABCD3, a peroxisomal long-chain fatty acid transporter, has been shown to serve as a prognostic factor in both prostate and colon cancers.

View Article and Find Full Text PDF